(AJMC) Apr 3, 2022 - Many oncologists oppose white bagging because they prefer to be able to adjust doses during a visit based on lab reports taken that day.
The rise of white bagging is wreaking havoc for patients and has spurred legislation in several states, according to 2 experts who said their oncology practices refuse to take part in the practice. With white bagging, pharmacy benefit managers (PBMs) require certain high-cost drugs to be shipped from their own specialty pharmacies to practices, where clinicians then administer the drugs to patients—assuming the drugs arrive safely and no dose changes are needed. READ MORE